参考文献/References:
[1] 吴 尚,李 兰,王 玉,等.射血分数保留心力衰竭治疗的研究进展[J].中华急诊医学杂志,2022,(3):417-421.
[2] 刘 薇,张玉焕,李 争.芪参益气滴丸对老年气虚血瘀型心力衰竭患者心肌保护、炎症状态的影响[J].陕西中医,2021,42(1):37-40.
[3] Abdul-Ghani M,Defronzo RA.Insulin resistance and hyperinsulinemia:The egg and the chicken[J].J Clin Endocrinol Metab,2021,106(4):e1897-e1899.
[4] Yaribeygi H,Farrokhi FR,Butler AE,et al.Insulin resistance:Review of the underlying molecular mechanisms[J].J Cell Physiol,2019,234(6):8152-8161.
[5] 陈开远,梁贵友.心肌胰岛素抵抗及其发生机制的研究进展[J].中华胸心血管外科杂志,2020,(7):442-446.
[6] Coskun ZM,Beydogan B,Yanar K,et al.Oxidative stress and inflammatory response of ghrelin on myocardial and aortic tissues in insulin-resistant rats[J].J Pharm Pharmacol,2021,73(5):692-699.
[7] 陈佳萍,缪兴龙,丁苗苗,等.益气活血祛瘀类中药及其复方防治心力衰竭的作用和机制[J].中国实验方剂学杂志,2022,28(21):221-234.
[8] Aimo A,Castiglione V,Borrelli C,et al.Oxidative stress and inflammation in the evolution of heart failure:From pathophysiology to therapeutic strategies[J].Eur J Prev Cardiol,2020,27(5):494-510.
[9] Kura B,Szeiffova-Bacova B,Kalocayova B,et al.Oxidative stress-responsive microRNas in heart injury[J].Int J Mol Sci,2020,21(1):358.
[10] Van-DerPol A,Van-Gilst WH,Voors AA,et al.Treating oxidative stress in heart failure:Past,present and future[J].Eur J Heart Fail,2019,21(4):425-435.
[11] Kolb H,Kempf K,Röhling M,et al.Insulin:Too much of a good thing is bad[J].BMC Med,2020,18(1):224.
[12] Zelniker TA,Braunwald E.Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors:JACC state-of-the-art review[J].J Am Coll Cardiol,2020,75(4):422-434.
[13] Valaei K,Taherkhani S,Arazi H,et al.Cardiac oxidative stress and the erapeutic approaches to the intake of antioxidant supplements and physical activity[J].Nutrients,2021,13(10):3483.
[14] 赵鑫龙,杨杰孚.心肌能量代谢与心力衰竭的研究进展[J].中华心血管病杂志,2022,50(4):404-409.
[15] 闫明静,沈 涛.线粒体功能障碍与血管内皮损伤的研究进展[J].中国动脉硬化杂志,2021,29(10):829-837.
[16] Garbincius JF,Elrod JW.Mitochondrial calcium exchange in physiology and disease[J].Physiol Rev,2022,102(2):893-992.
[17] 王丽艳,徐哲龙.线粒体功能障碍在心血管疾病中作用机制的研究进展[J].天津医药,2020,48(2):146-151.
[18] Saotome M,Ikoma T,Hasan P,et al.Cardiac insulin resistance in heart failure:The role of mitochondrial dynamics[J].Int J Mol Sci,2019,20(14):3552.
[19] Krestinina O,Baburina Y,Krestinin R.Mitochondrion as a target of astaxanthin therapy in heart failure[J].Int J Mol Sci,2021,22(15):7964.
[20] Lopaschuk GD,Karwi QG,Tian R,et al.Cardiac energy metabolism in heart failure[J].Circ Res,2021,128(10):1487-1513.
[21] 邢 昕,梁景辉,王世强.心肌细胞横管-肌质网耦联与钙信号调控[J].中国科学:生命科学,2022,52(1):5-16.
[22] Frisk M,Le C,Shen X,et al.Etiology-dependent impairment of diastolic cardiomyocyte calcium homeostasis in heart failure with preserved ejection fraction[J].J Am Coll Cardiol,2021,77(4):405-419.
[23] Pana TA,Dehghani M,Baradaran HR,et al.Calcium intake,calcium supplementation and cardiovascular disease and mortality in the British population:EPIC-norfolk prospective cohort study and meta-analysis[J].Eur J Epidemiol,2021,36(7):669-683.
[24] 李 茹,颜 旭.中医药干预内质网应激治疗慢性心力衰竭的研究进展[J].湖南中医杂志,2020,36(5):160-162.
[25] Ren J,BI Y,Sowers JR,et al.Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases[J].Nat Rev Cardiol,2021,18(7):499-521.
[26] 苏康康,王 岩,王立立,等.射血分数改善型心力衰竭的临床特点及预后研究[J].中国全科医学,2022,25(05):568-576.
[27] 杨荣军,史钰芳,王庆海.慢性心力衰竭与抑郁症共同发病机制及药物治疗的研究进展[J].中国全科医学,2022,25(5):625-630.
相似文献/References:
[1]周岩芬,张敏,周万保,等.NT-proBNP、肥胖及心力衰竭风险之间的相关性研究[J].陕西医学杂志,2016,(09):1163.
[2]张敏,张科林.托拉塞米联合多巴胺对老年顽固性心衰疗效及脑钠肽的影响[J].陕西医学杂志,2016,(09):1226.
[3]熊三军,马江伟,乔增勇.重组人脑利钠肽治疗心力衰竭临床效果及对患者尿量、心功能、炎症指标的影响[J].陕西医学杂志,2019,(1):99.
[4]倪凤扬,姬新才,吴可君,等.慢性心力衰竭患者血清胱抑素Ｃ水平与抑郁障碍相关性分析*[J].陕西医学杂志,2019,(4):425.
NI Fengyang,JI Xincai,WU Kejun,et al.The qssociation between Cystatin C and depression in patients with chronic heart failure[J].,2019,(4):425.
[5]龙继贤,高文妹.ST段抬高型急性心肌梗死早期脑钠肽水平变化及各个时间点检测对心力衰竭的诊断价值[J].陕西医学杂志,2019,(5):595.
LONG Jixian,GAO Wenmei..The change of brain natriuretic peptide(BNP)concentration in the early stage of STsegment elevationacute myocardial infarction and the diagnostic value of BNP at different time points for heart failure at that time[J].,2019,(4):595.
[6]王 颖,马思蕊,何 旭△.替米沙坦联合培哚普利治疗心力衰竭疗效及对患者左心室射血分数的影响[J].陕西医学杂志,2019,(8):1066.
WANG Ying,MA Sirui,HE Xu..Efficacy of telmisartan combined with perindopril in the treatment of heart failure and its
effect on left ventricular ejection fraction in patients[J].,2019,(4):1066.
[7]赵秀娟,雷晓慧.缩短分数、等容收缩时间等超声指标对异丙肾上腺素诱导的大鼠心肌损伤诊断价值研究[J].陕西医学杂志,2021,50(10):1179.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.001]
ZHAO Xiujuan,LEI Xiaohui.Diagnostic value of fraction shortening,iso volumetric contraction time and other ultrasound indicators in rats with isoprenaline-induced heart injury[J].,2021,50(4):1179.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.001]
[8]毕 月,史 娜.血清核苷酸结合寡聚化结构域样受体蛋白3水平与心力衰竭患者心电图QRS波时限关系[J].陕西医学杂志,2022,51(1):48.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.012]
[9]韩 媛,曾新春.半乳糖凝集素-3抑制剂柑橘果胶对心力衰竭大鼠血浆N端B型利钠肽原及心肌纤维化的影响[J].陕西医学杂志,2022,51(6):680.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.009]
HAN Yuan,ZENG Xinchun.Effects of Galectin-3 inhibitor citrus pectin on NT-proBNP and myocardial fibrosis in heart failure rats[J].,2022,51(4):680.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.009]